Literature DB >> 11269225

The Lambert-Eaton myasthenic syndrome.

A F Carpentier1, J Y Delattre.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11269225     DOI： 10.1385/CRIAI:20:1:155

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   10.817


× No keyword cloud information.
  24 in total

1.  Quantal components of end-plate potentials in the myasthenic syndrome.

Authors:  E H Lambert; D Elmqvist
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

2.  Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome.

Authors:  J Newsom-Davis; N M Murray
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

3.  Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome.

Authors:  P C Dau; E H Denys
Journal:  Ann Neurol       Date:  1982-06       Impact factor: 10.422

4.  Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG.

Authors:  Y I Kim
Journal:  Muscle Nerve       Date:  1986 Jul-Aug       Impact factor: 3.217

5.  Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.

Authors:  S D Meriney; S C Hulsizer; V A Lennon; A D Grinnell
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

6.  Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.

Authors:  C Arsac; C Raymond; N Martin-Moutot; B Dargent; F Couraud; J Pouget; M Seagar
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

7.  Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome.

Authors:  Y K Nakao; M Motomura; A Suenaga; T Nakamura; T Yoshimura; M Tsujihata; M Mori; M Itoh; S Nagataki
Journal:  J Neurol       Date:  1999-01       Impact factor: 4.849

8.  Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.

Authors:  V A Lennon; T J Kryzer; G E Griesmann; P E O'Suilleabhain; A J Windebank; A Woppmann; G P Miljanich; E H Lambert
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

9.  Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

Authors:  P G Bain; M Motomura; J Newsom-Davis; S A Misbah; H M Chapel; M L Lee; A Vincent; B Lang
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

10.  Autoimmunity in the Lambert-Eaton myasthenic syndrome.

Authors:  V A Lennon; E H Lambert; S Whittingham; V Fairbanks
Journal:  Muscle Nerve       Date:  1982       Impact factor: 3.217
View more
  1 in total

Review 1.  Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.

Authors:  Meleeneh Kazarian; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2011-03-30       Impact factor: 27.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.